Helen M Parsons

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Association between lymph node evaluation for colon cancer and node positivity over the past 20 years
    Helen M Parsons
    Applied Research Program, National Cancer Institute, Executive Plaza North, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    JAMA 306:1089-97. 2011
  2. pmc Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
    Helen M Parsons
    Applied Research Program, National Cancer Institute, Bethesda, MD 20892 7344, USA
    J Clin Oncol 29:4045-53. 2011
  3. pmc Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival
    Helen M Parsons
    From the Applied Research Program, National Cancer Institute, Bethesda, MD Information Management Services, Inc, Calverton, MD and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
    Cancer J 20:97-104. 2014

Detail Information

Publications3

  1. doi request reprint Association between lymph node evaluation for colon cancer and node positivity over the past 20 years
    Helen M Parsons
    Applied Research Program, National Cancer Institute, Executive Plaza North, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    JAMA 306:1089-97. 2011
    ..The presumed mechanism behind this association suggests that a more extensive lymph node evaluation reduces the risk of understaging, leading to improved survival...
  2. pmc Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
    Helen M Parsons
    Applied Research Program, National Cancer Institute, Bethesda, MD 20892 7344, USA
    J Clin Oncol 29:4045-53. 2011
    ..To identify current trends in AYA care, we examined patterns of clinical trial participation, time to treatment, and provider characteristics in a population-based sample of AYA patients with cancer...
  3. pmc Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival
    Helen M Parsons
    From the Applied Research Program, National Cancer Institute, Bethesda, MD Information Management Services, Inc, Calverton, MD and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
    Cancer J 20:97-104. 2014
    ..Whereas treatment patterns and outcomes have been evaluated for patients with SCLC in clinical trials, population-based practice patterns are not well known...